Prevention of post-stroke generalized anxiety disorder, Using escitalopram or problem- solving therapy

Katsunaka Mikami; Ricardo E. Jorge; David J. Moser; Stephan Arndt; Mijin Jang; Ana Solodkin; Steven L. Small; Pasquale Fonzetti; Mark T. Hegel; Robert G. Robinson

doi:10.1176/appi.neuropsych.11020047

Prevention of post-stroke generalized anxiety disorder, Using escitalopram or problem- solving therapy

Katsunaka Mikami, Ricardo E. Jorge, David J. Moser, Stephan Arndt, Mijin Jang, Ana Solodkin, Steven L. Small, Pasquale Fonzetti, Mark T. Hegel, Robert G. Robinson

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

This study examined the efficacy of antidepressant treatment for preventing the onset of generalized anxiety disorder (GAD) among patients with recent stroke. Of 799 patients assessed, 176 were randomized, and 149 patients without evidence of GAD at the initial visit were included in this doubleblind treatment with escitalopram (N=47) or placebo (N=49) or non-blinded problem-solving therapy (PST; 12 total sessions; N=53). Participants given placebo over 12 months were 4.95 times more likely to develop GAD than patients given escitalopram and 4.00 times more likely to develop GAD than patients given PST. Although these results should be considered preliminary, the authors found that both escitalopram and PST were effective in preventing new onset of post-stroke GAD.

Original language	English (US)
Pages (from-to)	323-328
Number of pages	6
Journal	Journal of Neuropsychiatry and Clinical Neurosciences
Volume	26
Issue number	4
DOIs	https://doi.org/10.1176/appi.neuropsych.11020047
State	Published - 2014
Externally published	Yes

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1176/appi.neuropsych.11020047

Cite this

@article{fb21de46545c48428f4511bacbb18f70,

title = "Prevention of post-stroke generalized anxiety disorder, Using escitalopram or problem- solving therapy",

abstract = "This study examined the efficacy of antidepressant treatment for preventing the onset of generalized anxiety disorder (GAD) among patients with recent stroke. Of 799 patients assessed, 176 were randomized, and 149 patients without evidence of GAD at the initial visit were included in this doubleblind treatment with escitalopram (N=47) or placebo (N=49) or non-blinded problem-solving therapy (PST; 12 total sessions; N=53). Participants given placebo over 12 months were 4.95 times more likely to develop GAD than patients given escitalopram and 4.00 times more likely to develop GAD than patients given PST. Although these results should be considered preliminary, the authors found that both escitalopram and PST were effective in preventing new onset of post-stroke GAD.",

author = "Katsunaka Mikami and Jorge, {Ricardo E.} and Moser, {David J.} and Stephan Arndt and Mijin Jang and Ana Solodkin and Small, {Steven L.} and Pasquale Fonzetti and Hegel, {Mark T.} and Robinson, {Robert G.}",

note = "Publisher Copyright: {\textcopyright} 2014 American Psychiatric Association.",

year = "2014",

doi = "10.1176/appi.neuropsych.11020047",

language = "English (US)",

volume = "26",

pages = "323--328",

journal = "Journal of Neuropsychiatry and Clinical Neurosciences",

issn = "0895-0172",

publisher = "American Psychiatric Publishing Inc.",

number = "4",

}

TY - JOUR

T1 - Prevention of post-stroke generalized anxiety disorder, Using escitalopram or problem- solving therapy

AU - Mikami, Katsunaka

AU - Jorge, Ricardo E.

AU - Moser, David J.

AU - Arndt, Stephan

AU - Jang, Mijin

AU - Solodkin, Ana

AU - Small, Steven L.

AU - Fonzetti, Pasquale

AU - Hegel, Mark T.

AU - Robinson, Robert G.

PY - 2014

Y1 - 2014

N2 - This study examined the efficacy of antidepressant treatment for preventing the onset of generalized anxiety disorder (GAD) among patients with recent stroke. Of 799 patients assessed, 176 were randomized, and 149 patients without evidence of GAD at the initial visit were included in this doubleblind treatment with escitalopram (N=47) or placebo (N=49) or non-blinded problem-solving therapy (PST; 12 total sessions; N=53). Participants given placebo over 12 months were 4.95 times more likely to develop GAD than patients given escitalopram and 4.00 times more likely to develop GAD than patients given PST. Although these results should be considered preliminary, the authors found that both escitalopram and PST were effective in preventing new onset of post-stroke GAD.

AB - This study examined the efficacy of antidepressant treatment for preventing the onset of generalized anxiety disorder (GAD) among patients with recent stroke. Of 799 patients assessed, 176 were randomized, and 149 patients without evidence of GAD at the initial visit were included in this doubleblind treatment with escitalopram (N=47) or placebo (N=49) or non-blinded problem-solving therapy (PST; 12 total sessions; N=53). Participants given placebo over 12 months were 4.95 times more likely to develop GAD than patients given escitalopram and 4.00 times more likely to develop GAD than patients given PST. Although these results should be considered preliminary, the authors found that both escitalopram and PST were effective in preventing new onset of post-stroke GAD.

UR - http://www.scopus.com/inward/record.url?scp=84912007110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912007110&partnerID=8YFLogxK

U2 - 10.1176/appi.neuropsych.11020047

DO - 10.1176/appi.neuropsych.11020047

M3 - Article

C2 - 24457590

AN - SCOPUS:84912007110

SN - 0895-0172

VL - 26

SP - 323

EP - 328

JO - Journal of Neuropsychiatry and Clinical Neurosciences

JF - Journal of Neuropsychiatry and Clinical Neurosciences

IS - 4

ER -

Prevention of post-stroke generalized anxiety disorder, Using escitalopram or problem- solving therapy

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this